It was a slow month for next generation Covid vaccine results reporting, but a big month for clinical trial news:
- A new clinical trial for intranasal and inhaled versions of a vax is on the starting blocks in the US;
- Another intranasal vax trial has expanded to another 2 cities in the US; and
- A trial for a "variant-proof" vax going into phase 2a trial in Germany.
Plus some preclinical reports & more in my latest monthly update @PLOS
